Welcome to LookChem.com Sign In|Join Free

CAS

  • or

114681-65-1

Post Buying Request

114681-65-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

114681-65-1 Usage

Uses

RGD peptide (GRGDNP) is an inhibitor of integrin-ligand interactions.

Check Digit Verification of cas no

The CAS Registry Mumber 114681-65-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,4,6,8 and 1 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 114681-65:
(8*1)+(7*1)+(6*4)+(5*6)+(4*8)+(3*1)+(2*6)+(1*5)=121
121 % 10 = 1
So 114681-65-1 is a valid CAS Registry Number.

114681-65-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name H-Gly-Arg-Gly-Asp-Asn-Pro-OH

1.2 Other means of identification

Product number -
Other names GRGDNP

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:114681-65-1 SDS

114681-65-1Upstream product

114681-65-1Downstream Products

114681-65-1Relevant articles and documents

Fibrinogen-coated particles for therapeutic use

-

, (2008/06/13)

The invention provides a particle comprising fibrinogen bound on the surface of an albumin matrix, wherein said particle is capable of coaggregation with platelet, and of aggregation in a solution containing soluble fibrinogen at a concentration of soluble fibrinogen not capable by it self of formation of a clot upon activation by thrombin.

Non-crosslinked protein particles for therapeutic and diagnostic use

-

, (2008/06/13)

Albumin particles in the nanometer and micrometer size range in an aqueous suspension are rendered stable against resolubilization without the aid of a crosslinking agent and without denaturation, by the incorporation of hemoglobin in the particle composition. Particles which are primarily hemoglobin in the nanometer and micrometer size range in an aqueous suspension are rendered stable against aggregation by the incorporation of either albumin, surface active agents or gelatin.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 114681-65-1